298 related articles for article (PubMed ID: 30820734)
1. Trends in the Incidence, Treatment and Outcomes of Patients with Intrahepatic Cholangiocarcinoma in the USA: Facility Type is Associated with Margin Status, Use of Lymphadenectomy and Overall Survival.
Wu L; Tsilimigras DI; Paredes AZ; Mehta R; Hyer JM; Merath K; Sahara K; Bagante F; Beal EW; Shen F; Pawlik TM
World J Surg; 2019 Jul; 43(7):1777-1787. PubMed ID: 30820734
[TBL] [Abstract][Full Text] [Related]
2. Facility Type is Associated with Margin Status and Overall Survival of Patients with Resected Intrahepatic Cholangiocarcinoma.
Lee GC; Gamblin TC; Fong ZV; Ferrone CR; Goyal L; Lillemoe KD; Blaszkowsky LS; Tanabe KK; Qadan M
Ann Surg Oncol; 2019 Nov; 26(12):4091-4099. PubMed ID: 31368018
[TBL] [Abstract][Full Text] [Related]
3. Hilar cholangiocarcinoma: the Memorial Sloan-Kettering Cancer Center experience.
Rocha FG; Matsuo K; Blumgart LH; Jarnagin WR
J Hepatobiliary Pancreat Sci; 2010 Jul; 17(4):490-6. PubMed ID: 19806295
[TBL] [Abstract][Full Text] [Related]
4. Is Radiotherapy Warranted Following Intrahepatic Cholangiocarcinoma Resection? The Impact of Surgical Margins and Lymph Node Status on Survival.
Hammad AY; Berger NG; Eastwood D; Tsai S; Turaga KK; Christian KK; Johnston FM; Pawlik TM; Gamblin TC
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):912-920. PubMed ID: 27654107
[TBL] [Abstract][Full Text] [Related]
5. Lymphadenectomy in the staging and treatment of intrahepatic cholangiocarcinoma: a population-based study using the National Cancer Institute SEER database.
Clark CJ; Wood-Wentz CM; Reid-Lombardo KM; Kendrick ML; Huebner M; Que FG
HPB (Oxford); 2011 Sep; 13(9):612-20. PubMed ID: 21843261
[TBL] [Abstract][Full Text] [Related]
6. Lymphadenectomy for Intrahepatic Cholangiocarcinoma: Has Nodal Evaluation Been Increasingly Adopted by Surgeons over Time?A National Database Analysis.
Zhang XF; Chen Q; Kimbrough CW; Beal EW; Lv Y; Chakedis J; Dillhoff M; Schmidt C; Cloyd J; Pawlik TM
J Gastrointest Surg; 2018 Apr; 22(4):668-675. PubMed ID: 29264768
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of lymphadenectomy for long-term outcomes in node-negative intrahepatic cholangiocarcinoma: A multicenter study.
Yoh T; Cauchy F; Le Roy B; Seo S; Taura K; Hobeika C; Dokmak S; Farges O; Gelli M; Sa Cunha A; Adam R; Uemoto S; Soubrane O
Surgery; 2019 Dec; 166(6):975-982. PubMed ID: 31421869
[TBL] [Abstract][Full Text] [Related]
8. The Impact of Surgical Margin Status on Long-Term Outcome After Resection for Intrahepatic Cholangiocarcinoma.
Spolverato G; Yakoob MY; Kim Y; Alexandrescu S; Marques HP; Lamelas J; Aldrighetti L; Gamblin TC; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Marsh JW; Pawlik TM
Ann Surg Oncol; 2015 Nov; 22(12):4020-8. PubMed ID: 25762481
[TBL] [Abstract][Full Text] [Related]
9. The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival.
Choi SB; Kim KS; Choi JY; Park SW; Choi JS; Lee WJ; Chung JB
Ann Surg Oncol; 2009 Nov; 16(11):3048-56. PubMed ID: 19626372
[TBL] [Abstract][Full Text] [Related]
10. Pathological confirmation of para-aortic lymph node status as a potential criterion for the selection of intrahepatic cholangiocarcinoma patients for radical resection with regional lymph node dissection.
Nakayama T; Tsuchikawa T; Shichinohe T; Nakamura T; Ebihara Y; Hirano S
World J Surg; 2014 Jul; 38(7):1763-8. PubMed ID: 24378552
[TBL] [Abstract][Full Text] [Related]
11. Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection.
Endo I; Gonen M; Yopp AC; Dalal KM; Zhou Q; Klimstra D; D'Angelica M; DeMatteo RP; Fong Y; Schwartz L; Kemeny N; O'Reilly E; Abou-Alfa GK; Shimada H; Blumgart LH; Jarnagin WR
Ann Surg; 2008 Jul; 248(1):84-96. PubMed ID: 18580211
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma.
Li SQ; Liang LJ; Hua YP; Peng BG; He Q; Lu MD; Chen D
Chin Med J (Engl); 2009 Oct; 122(19):2286-91. PubMed ID: 20079127
[TBL] [Abstract][Full Text] [Related]
13. Surgical treatment for intrahepatic cholangiocarcinoma in Europe: a single center experience.
Bektas H; Yeyrek C; Kleine M; Vondran FW; Timrott K; Schweitzer N; Vogel A; Jäger MD; Schrem H; Klempnauer J; Kousoulas L
J Hepatobiliary Pancreat Sci; 2015 Feb; 22(2):131-7. PubMed ID: 25159731
[TBL] [Abstract][Full Text] [Related]
14. Prognosis after resection for hepatitis B virus-associated intrahepatic cholangiocarcinoma.
Wu ZF; Wu XY; Zhu N; Xu Z; Li WS; Zhang HB; Yang N; Yao XQ; Liu FK; Yang GS
World J Gastroenterol; 2015 Jan; 21(3):935-43. PubMed ID: 25624728
[TBL] [Abstract][Full Text] [Related]
15. Effect of surgical margin width after R0 resection for intrahepatic cholangiocarcinoma: A nationwide survey of the Liver Cancer Study Group of Japan.
Watanabe Y; Matsuyama Y; Izumi N; Kubo S; Kokudo N; Sakamoto M; Shiina S; Takayama T; Nakashima O; Kudo M
Surgery; 2020 May; 167(5):793-802. PubMed ID: 32044110
[TBL] [Abstract][Full Text] [Related]
16. Impact of lymph node status in patients with intrahepatic cholangiocarcinoma treated by major hepatectomy: a review of the National Cancer Database.
Jutric Z; Johnston WC; Hoen HM; Newell PH; Cassera MA; Hammill CW; Wolf RF; Hansen PD
HPB (Oxford); 2016 Jan; 18(1):79-87. PubMed ID: 26776855
[TBL] [Abstract][Full Text] [Related]
17. Safety and feasibility of laparoscopic liver resection with associated lymphadenectomy for intrahepatic cholangiocarcinoma: a propensity score-based case-matched analysis from a single institution.
Ratti F; Cipriani F; Ariotti R; Gagliano A; Paganelli M; Catena M; Aldrighetti L
Surg Endosc; 2016 May; 30(5):1999-2010. PubMed ID: 26194257
[TBL] [Abstract][Full Text] [Related]
18. Clinical impact of the surgical margin status in hepatectomy for solitary mass-forming type intrahepatic cholangiocarcinoma without lymph node metastases.
Shimada K; Sano T; Sakamoto Y; Esaki M; Kosuge T; Ojima H
J Surg Oncol; 2007 Aug; 96(2):160-5. PubMed ID: 17443744
[TBL] [Abstract][Full Text] [Related]
19. Recurrence Patterns and Timing Courses Following Curative-Intent Resection for Intrahepatic Cholangiocarcinoma.
Hu LS; Zhang XF; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Itaru E; Pawlik TM
Ann Surg Oncol; 2019 Aug; 26(8):2549-2557. PubMed ID: 31020501
[TBL] [Abstract][Full Text] [Related]
20. Implications of Intrahepatic Cholangiocarcinoma Etiology on Recurrence and Prognosis after Curative-Intent Resection: a Multi-Institutional Study.
Zhang XF; Chakedis J; Bagante F; Beal EW; Lv Y; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Groot Koerkamp B; Guglielmi A; Itaru E; Pawlik TM
World J Surg; 2018 Mar; 42(3):849-857. PubMed ID: 28879598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
